Results 141 to 150 of about 1,090 (156)

Facteurs pronostiques de bonne récupération d’une neuropathie optique dysthyroïdienne prise en charge selon les recommandations EUGOGO, série lyonnaise de 69 yeux de 38 patients

Annales D'Endocrinologie, 2022
J Orgiazzi, F Borson-Chazot
exaly   +2 more sources

The EUGOGO Consensus Statement on the Management of Graves' Orbitopathy: Equally Applicable to North American Clinicians and Patients

Thyroid, 2008
exaly   +2 more sources

L’ophtalmopathie thyroïdienne à l’heure de l’European Group On Graves Orbitopathy (EUGOGO)

Presse Medicale, 2011
Thyroid ophthalmopathy is one of the features of auto-immune thyroid diseases. Exophtalmos is not the only sign of this affection and may even be absent in severe sight-threatening cases. All subjects with this ophtalmopathy should benefit from euthyroidism restoration, smoking withdrawal and local measures.
exaly   +2 more sources

Declaración de consenso del Grupo europeo sobre la orbitopatía de Graves (EUGOGO) sobre el tratamiento de la orbitopatía de Graves (OG)

Endocrinologia Y Nutricion: Organo De La Sociedad Espanola De Endocrinologia Y Nutricion, 2008
Petros Perros, Luigi Bartalena
exaly   +3 more sources

New Approaches to Treatment of Patients with Autoimmune Ophthalmopathy (the Review of the 2016 and 2021 Clinical Practice Guidelines of the European Group of Graves’ Orbitopathy (EUGOGO) for the Management of Graves’ Orbitopathy Endorsed by the European Society of Endocrinology (ESE))

Рецепт, 2022
Лечение аутоиммунной офтальмопатии (АИО) остается непростой задачей для клиницистов, требует пациентоориентированного подхода и анализа эффективности каждого этапа терапии. В обновленных рекомендациях четко прописан алгоритм лечения АИО с выделением терапии первого и второго уровня. Глюкокортикоиды остаются первой линией терапии.
openaire   +1 more source

[Thyroid ophthalmopathy at the time of European Group On Graves Orbitopathy (EUGOGO)].

Presse medicale (Paris, France : 1983), 2012
Thyroid ophthalmopathy is one of the features of auto-immune thyroid diseases. Exophtalmos is not the only sign of this affection and may even be absent in severe sight-threatening cases. All subjects with this ophtalmopathy should benefit from euthyroidism restoration, smoking withdrawal and local measures.
openaire   +1 more source

Obravnava bolnikov s ščitnično orbitopatijo, upoštevanje priporočila EUGOGO (European group on Graves' orbitopathy): Management of patients with graves' orbitopathy according to EUGOGO (European group on Graves' orbitopathy) consensus statement:

2010
Background: Graves' orbitopathy is the most common non-thyroid sign of Graves' disease. The disease has a clinical course with various grades of severity, and is self-limited in the long run. However, severe forms of the disease require prompt medical and surgical treatment. A multidisciplinary approach is necessary. Conclusions: The aim of the article
Beltram, Matej, Jaki Mekjavić, Polona
openaire   +1 more source

Retro-orbital radiotherapy and systemic steroid therapy in thyroid eye disease: A ten-year audit against EUGOGO guidelines

Clinical Oncology, 2022
Maria Moleron, Leslie Samuel, Jillian Moses, John Olson   +3 more
openaire   +1 more source

Faculty Opinions recommendation of The 2021 European Group on Graves' orbitopathy (EUGOGO) clinical practice guidelines for the medical management of Graves' orbitopathy.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature, 2021
openaire   +2 more sources

Thyroid eye disease: current concepts and the EUGOGO perspective

Thyroid, 2005
Krassas, G. E., Wiersinga, W. M.
openaire   +1 more source